Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells

Tokuhiro Chano, Shiro Ikegawa, Keiichi Kontani, Hidetoshi Okabe, Nicola Baldini, Yukikazu Saeki

Research output: Contribution to journalArticle

Abstract

Multidrug resistance to anti-cancer agents (MDR) is a major barrier to successful cancer treatment. Current knowledge about genes that contribute to MDR is limited, however, and its mechanisms remain unclear. To identify genes involved in MDR, we performed differential display analysis and isolated a novel human gene, RB1CC1 (RBI-inducible Coiled-Coil 1). The 6.6-kb RB1CC1 cDNA encodes a putative 1594-amino-acid protein that contains a nuclear localization signal, a leucine zipper motif and a coiled-coil structure. Western blot analysis and immunocytochemical staining with anti-RB1CC1 antibody showed that endogenously expressed RB1CC1 protein localized to the nucleus. In MDR variants of human osteosarcoma cells, RB1CC1 expression increased in response to doxorubicin-induced cytotoxic stress and remained elevated for the duration of drug treatment. RB1CC1 expression levels correlated closely with those of RB1 (retinoblastoma 1) in cancer cell lines as well as in various normal human tissues. Moreover, introduction of wild-type RB1CC1 significantly induced RB1 expression in human leukemic cells. These data suggest that RB1CC1 may be a key regulator of RB1 gene expression.

Original languageEnglish
Pages (from-to)1295-1298
Number of pages4
JournalOncogene
Volume21
Issue number8
DOIs
Publication statusPublished - Feb 14 2002

Fingerprint

Retinoblastoma
Genes
Retinoblastoma Genes
Leucine Zippers
Nuclear Localization Signals
Neoplasms
Multiple Drug Resistance
Osteosarcoma
Doxorubicin
Anti-Idiotypic Antibodies
Proteins
Complementary DNA
Western Blotting
Staining and Labeling
Gene Expression
Amino Acids
Cell Line
Pharmaceutical Preparations

Keywords

  • MDR (multidrug resistance)
  • Neoplasm
  • RB1 (retinoblastoma 1)
  • RB1CC1 (RB1-inducible coiled-coil 1)

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. / Chano, Tokuhiro; Ikegawa, Shiro; Kontani, Keiichi; Okabe, Hidetoshi; Baldini, Nicola; Saeki, Yukikazu.

In: Oncogene, Vol. 21, No. 8, 14.02.2002, p. 1295-1298.

Research output: Contribution to journalArticle

Chano, T, Ikegawa, S, Kontani, K, Okabe, H, Baldini, N & Saeki, Y 2002, 'Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells', Oncogene, vol. 21, no. 8, pp. 1295-1298. https://doi.org/10.1038/sj/onc/1205178
Chano, Tokuhiro ; Ikegawa, Shiro ; Kontani, Keiichi ; Okabe, Hidetoshi ; Baldini, Nicola ; Saeki, Yukikazu. / Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. In: Oncogene. 2002 ; Vol. 21, No. 8. pp. 1295-1298.
@article{d827be8b58ca4781b532a51cf02d2a36,
title = "Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells",
abstract = "Multidrug resistance to anti-cancer agents (MDR) is a major barrier to successful cancer treatment. Current knowledge about genes that contribute to MDR is limited, however, and its mechanisms remain unclear. To identify genes involved in MDR, we performed differential display analysis and isolated a novel human gene, RB1CC1 (RBI-inducible Coiled-Coil 1). The 6.6-kb RB1CC1 cDNA encodes a putative 1594-amino-acid protein that contains a nuclear localization signal, a leucine zipper motif and a coiled-coil structure. Western blot analysis and immunocytochemical staining with anti-RB1CC1 antibody showed that endogenously expressed RB1CC1 protein localized to the nucleus. In MDR variants of human osteosarcoma cells, RB1CC1 expression increased in response to doxorubicin-induced cytotoxic stress and remained elevated for the duration of drug treatment. RB1CC1 expression levels correlated closely with those of RB1 (retinoblastoma 1) in cancer cell lines as well as in various normal human tissues. Moreover, introduction of wild-type RB1CC1 significantly induced RB1 expression in human leukemic cells. These data suggest that RB1CC1 may be a key regulator of RB1 gene expression.",
keywords = "MDR (multidrug resistance), Neoplasm, RB1 (retinoblastoma 1), RB1CC1 (RB1-inducible coiled-coil 1)",
author = "Tokuhiro Chano and Shiro Ikegawa and Keiichi Kontani and Hidetoshi Okabe and Nicola Baldini and Yukikazu Saeki",
year = "2002",
month = "2",
day = "14",
doi = "10.1038/sj/onc/1205178",
language = "English",
volume = "21",
pages = "1295--1298",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells

AU - Chano, Tokuhiro

AU - Ikegawa, Shiro

AU - Kontani, Keiichi

AU - Okabe, Hidetoshi

AU - Baldini, Nicola

AU - Saeki, Yukikazu

PY - 2002/2/14

Y1 - 2002/2/14

N2 - Multidrug resistance to anti-cancer agents (MDR) is a major barrier to successful cancer treatment. Current knowledge about genes that contribute to MDR is limited, however, and its mechanisms remain unclear. To identify genes involved in MDR, we performed differential display analysis and isolated a novel human gene, RB1CC1 (RBI-inducible Coiled-Coil 1). The 6.6-kb RB1CC1 cDNA encodes a putative 1594-amino-acid protein that contains a nuclear localization signal, a leucine zipper motif and a coiled-coil structure. Western blot analysis and immunocytochemical staining with anti-RB1CC1 antibody showed that endogenously expressed RB1CC1 protein localized to the nucleus. In MDR variants of human osteosarcoma cells, RB1CC1 expression increased in response to doxorubicin-induced cytotoxic stress and remained elevated for the duration of drug treatment. RB1CC1 expression levels correlated closely with those of RB1 (retinoblastoma 1) in cancer cell lines as well as in various normal human tissues. Moreover, introduction of wild-type RB1CC1 significantly induced RB1 expression in human leukemic cells. These data suggest that RB1CC1 may be a key regulator of RB1 gene expression.

AB - Multidrug resistance to anti-cancer agents (MDR) is a major barrier to successful cancer treatment. Current knowledge about genes that contribute to MDR is limited, however, and its mechanisms remain unclear. To identify genes involved in MDR, we performed differential display analysis and isolated a novel human gene, RB1CC1 (RBI-inducible Coiled-Coil 1). The 6.6-kb RB1CC1 cDNA encodes a putative 1594-amino-acid protein that contains a nuclear localization signal, a leucine zipper motif and a coiled-coil structure. Western blot analysis and immunocytochemical staining with anti-RB1CC1 antibody showed that endogenously expressed RB1CC1 protein localized to the nucleus. In MDR variants of human osteosarcoma cells, RB1CC1 expression increased in response to doxorubicin-induced cytotoxic stress and remained elevated for the duration of drug treatment. RB1CC1 expression levels correlated closely with those of RB1 (retinoblastoma 1) in cancer cell lines as well as in various normal human tissues. Moreover, introduction of wild-type RB1CC1 significantly induced RB1 expression in human leukemic cells. These data suggest that RB1CC1 may be a key regulator of RB1 gene expression.

KW - MDR (multidrug resistance)

KW - Neoplasm

KW - RB1 (retinoblastoma 1)

KW - RB1CC1 (RB1-inducible coiled-coil 1)

UR - http://www.scopus.com/inward/record.url?scp=0037075233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037075233&partnerID=8YFLogxK

U2 - 10.1038/sj/onc/1205178

DO - 10.1038/sj/onc/1205178

M3 - Article

C2 - 11850849

VL - 21

SP - 1295

EP - 1298

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 8

ER -